- Titre
- Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study) (vol 46, 100915, 2024)
- Créateurs - sans rôle
- Pascal Demoly - InsermMathieu Molimard - Bordeaux Univ, Dept Med Pharmacol, Bordeaux, FranceJean-Francois Bergmann - Univ Paris Cite, Lariboisiere Hosp, AP HP, Dept Internal Med, Paris, FranceBertrand Delaisi - Clin Marcel Sembat, Inst Enfant, Boulogne Billancourt, FranceAmandine Gouverneur - IQVIA, RWS, Paris, FranceJade Vadel - IQVIA, RWS, Paris, FranceCedric Collin - IQVIA, RWS, Paris, FranceLaurence Girard - Stallergenes Greer, Antony, FranceSilvia Scurati - Stallergenes Greer, Antony, FrancePhilippe Devillier - Univ Versailles St Quentin, VIM Suresnes UMR 0892, Foch Hosp, Airway Dis Dept, Suresnes, France
- Détails de publication
- The Lancet regional health. Europe, Vol.46, 101120
- Éditeur
- Elsevier
- Nombre de pages
- 5
- Identifiants
- 99149972409311
- Unité académique
- Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study) (vol 46, 100915, 2024)
The Lancet regional health. Europe, Vol.46, 101120
01/11/2024
PMID: 39498359
Indicateurs
1 Consultations de la notice